HK1218959A1 - 雷帕霉素衍生物的純化 - Google Patents

雷帕霉素衍生物的純化

Info

Publication number
HK1218959A1
HK1218959A1 HK16107001.4A HK16107001A HK1218959A1 HK 1218959 A1 HK1218959 A1 HK 1218959A1 HK 16107001 A HK16107001 A HK 16107001A HK 1218959 A1 HK1218959 A1 HK 1218959A1
Authority
HK
Hong Kong
Prior art keywords
purification
rapamycin derivatives
rapamycin
derivatives
Prior art date
Application number
HK16107001.4A
Other languages
English (en)
Inventor
Margaret W Kayo
Richard S Fornicola
Ivan Kovacik
Leelakrishna Kondaveti
Aniruddh Singh
Original Assignee
Biosensors Int Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosensors Int Group Ltd filed Critical Biosensors Int Group Ltd
Publication of HK1218959A1 publication Critical patent/HK1218959A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
HK16107001.4A 2013-03-15 2016-06-17 雷帕霉素衍生物的純化 HK1218959A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361799857P 2013-03-15 2013-03-15
PCT/US2014/030602 WO2014145780A1 (en) 2013-03-15 2014-03-17 Purification of rapamycin derivatives

Publications (1)

Publication Number Publication Date
HK1218959A1 true HK1218959A1 (zh) 2017-03-17

Family

ID=51538094

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16107001.4A HK1218959A1 (zh) 2013-03-15 2016-06-17 雷帕霉素衍生物的純化

Country Status (9)

Country Link
US (5) US9598439B2 (zh)
EP (1) EP2972258B1 (zh)
JP (4) JP2016519086A (zh)
CN (2) CN108864149B (zh)
CA (1) CA2901162C (zh)
ES (1) ES2897473T3 (zh)
HK (1) HK1218959A1 (zh)
SG (3) SG11201507406YA (zh)
WO (1) WO2014145780A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012005012A (es) 2009-11-02 2012-07-20 Pulse Therapeutics Inc Sistema de estator magnetomotriz y metodos para control inalambrico de rotores magneticos.
CN108864149B (zh) 2013-03-15 2022-04-05 生物传感器国际集团有限公司 雷帕霉素衍生物的纯化
CN109851626B (zh) * 2019-01-08 2021-11-02 扬子江药业集团四川海蓉药业有限公司 一种替西罗莫司的分离纯化方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds
US20060198867A1 (en) * 1997-09-25 2006-09-07 Abbott Laboratories, Inc. Compositions and methods of administering rapamycin analogs using medical devices for long-term efficacy
US7452692B2 (en) 2002-02-13 2008-11-18 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Method for extracting a macrolide from biomatter
US7232486B2 (en) * 2003-03-31 2007-06-19 TEVA Gyógyszergyár Zártkörűen Működő Részvénytársaság Crystallization and purification of macrolides
US7220755B2 (en) * 2003-11-12 2007-05-22 Biosensors International Group, Ltd. 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same
AU2003286417A1 (en) * 2003-12-05 2005-06-24 Biocon Limited Process for the purification of macrolides
JP4716280B2 (ja) * 2004-03-01 2011-07-06 テルモ株式会社 Ｏ−アルキル化ラパマイシン誘導体の製造法
MXPA06011881A (es) * 2004-04-14 2006-12-14 Wyeth Corp Sintesis regioespecifica de derivados de ester-42 de rapamicina.
JP2007519757A (ja) 2004-12-01 2007-07-19 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ ピメクロリマスの調製方法
MX2007010716A (es) * 2005-03-02 2008-01-16 Wyeth Corp Purificacion de rapamicina.
US20060222627A1 (en) * 2005-03-30 2006-10-05 Andrew Carter Optimizing pharmacodynamics of therapeutic agents for treating vascular tissue
JP2009518648A (ja) * 2005-12-07 2009-05-07 ワイス 結晶性ラパマイシンを調製するための方法およびを示差走査熱量測定使用してラパマイシン化合物の結晶化度を測定するための方法
US7700614B2 (en) * 2005-12-14 2010-04-20 Abbott Laboratories One pot synthesis of tetrazole derivatives of rapamycin
GB0601406D0 (en) * 2006-01-24 2006-03-08 Novartis Ag Organic Compounds
EP1993610A2 (en) 2006-03-07 2008-11-26 Wyeth Process for preparing water-soluble polyethylene glycol conjugates of macrolide immunosuppressants
US7820812B2 (en) * 2006-07-25 2010-10-26 Abbott Laboratories Methods of manufacturing crystalline forms of rapamycin analogs
US7812032B2 (en) * 2006-07-25 2010-10-12 Abbott Laboratories Crystalline forms of rapamycin analogs
US20100029933A1 (en) * 2006-11-10 2010-02-04 Biocon Limited Pure form of rapamycin and a process for recovery and purification thereof
WO2008065887A1 (fr) * 2006-11-27 2008-06-05 Terumo Kabushiki Kaisha Procédé de fabrication d'un dérivé de rapamycine o-alkylé, et dérivé de rapamycine o-alkylée
US20080287675A1 (en) * 2007-05-18 2008-11-20 Abbott Laboratories Cascade system
CN101077334A (zh) * 2007-06-29 2007-11-28 济南康泉医药科技有限公司 含酪氨酸激酶抑制剂的抗癌组合物
TW200948361A (en) * 2008-05-26 2009-12-01 Chunghwa Chemical Synthesis & Biotech Co Ltd Method for synthesizing Biolimus A9 and the like and method for improving stability of the same
US20100055145A1 (en) * 2008-08-29 2010-03-04 Biosensors International Group Stent coatings for reducing late stent thrombosis
EP2421571A2 (en) 2009-04-24 2012-02-29 Boston Scientific Scimed, Inc. Use of drug polymorphs to achieve controlled drug delivery from a coated medical device
CN102464669B (zh) * 2010-11-17 2014-04-16 浙江海正药业股份有限公司 无定形依维莫司及其制备方法
WO2013022458A1 (en) * 2011-08-05 2013-02-14 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
US9056152B2 (en) * 2011-08-25 2015-06-16 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
CN102786534A (zh) * 2012-05-25 2012-11-21 上海现代制药股份有限公司 一种依维莫司的制备方法
CN108864149B (zh) 2013-03-15 2022-04-05 生物传感器国际集团有限公司 雷帕霉素衍生物的纯化

Also Published As

Publication number Publication date
CA2901162A1 (en) 2014-09-18
US10202402B2 (en) 2019-02-12
US20220024947A1 (en) 2022-01-27
CN105102967B (zh) 2018-10-12
EP2972258A4 (en) 2016-12-21
SG10202112135VA (en) 2021-12-30
JP2019089848A (ja) 2019-06-13
SG11201507406YA (en) 2015-10-29
CN108864149A (zh) 2018-11-23
US11780850B2 (en) 2023-10-10
US20160002262A1 (en) 2016-01-07
US11046711B2 (en) 2021-06-29
US10597406B2 (en) 2020-03-24
US9598439B2 (en) 2017-03-21
WO2014145780A1 (en) 2014-09-18
US20200270272A1 (en) 2020-08-27
EP2972258B1 (en) 2021-08-04
WO2014145780A4 (en) 2014-11-20
CA2901162C (en) 2021-06-01
JP2016519086A (ja) 2016-06-30
EP2972258A1 (en) 2016-01-20
SG10201707632PA (en) 2017-11-29
CN105102967A (zh) 2015-11-25
ES2897473T3 (es) 2022-03-01
CN108864149B (zh) 2022-04-05
US20190256527A1 (en) 2019-08-22
US20170334928A1 (en) 2017-11-23
JP2021121601A (ja) 2021-08-26
JP2023164476A (ja) 2023-11-10

Similar Documents

Publication Publication Date Title
HK1221466A1 (zh) 作為 抑制劑的聯吡唑衍生物
PL2803401T3 (pl) Oczyszczanie powietrza
HK1216429A1 (zh) 用於純化芳基硫酸酯酶 的方法
HRP20181710T1 (hr) Uporaba derivata benzimidazol-prolina
AR092198A1 (es) Derivados de pirazolopirimidinas
ZA201602198B (en) Preparation of hydroxy-benzylbenzene derivatives
EP2948557A4 (en) PURIFICATION OF CADAVERINE
ZA201602831B (en) Use of lactones
HK1218959A1 (zh) 雷帕霉素衍生物的純化
HK1218118A1 (zh) 雷帕霉素衍生物的低温合成
GB201314581D0 (en) Purification